Transcript UKMEC - Barnsley VTS

UKMEC
UK WHAT?

The United Kingdom Medical Eligibility Criteria
Most contraceptive users are medically fit and can
use any contraceptive method safely
 However, some medical conditions lead to a
theoretically increased health risk when certain
contraceptive methods are used
 Most trials of new contraceptives deliberately exclude
those with chronic medical conditions


Little direct evidence for safe prescribing
WHOMEC
Developed by the WHO for international
organisations to update or develop their own
guidelines in line with national health policies,
resources etc.
 Last updated 2008

UKMEC
First published in 2006
 Aimed at contraceptive use for contraceptive
purposes, as there may be a different risk-benefit
profile in other cases
 Criteria relate to the safety of using a
contraceptive method by women with certain
medical conditions or using certain drugs

UKMEC


UKMEC 2009 supersedes the 2006 version and
uses evidence from the WHOMEC 4th edition
It’s not easy to summarise…
CATEGORIES
COMMONLY USED CONTRACEPTIVE
METHODS
CHC – Combined Hormonal Contraception
 POP – Progestogen Only Pill
 DMPA – Depot Medroxyprogesterone Acetate
 NET-EN – Norethisterone Enantanate
 IMP – Implant (Progesterone Only)
 Cu-IUD – Copper Coil
 LNG-IUD – Levonorgestrel Releasing IUD

WHAT SORT OF THINGS MAKE A
DIFFERENCE?
CONSIDERATIONS

Female Factors:














Breastfeeding
Post-partum
Abortion
Gestational hypertension
Unexplained Vaginal
Bleeding
Dysmenorrhoea
Gestational Trophoblastic
Disease
CIN
Cervical Cancer
Breast Disease
Endometrial Ca
Ovarian Ca
Fibroids
Anatomical Abnormalities

Infections




STI
HIV / AIDS
TB
Hepatitis
CONSIDERATIONS

Cancers






Cervical Cancer
Breast Cancer
Endometrial Ca
Ovarian Ca
Anatomical
Abnormalities
Liver tumours

GI Conditions






Diabetes
Gallbladder Disease
Cholestasis
Cirrhosis
Liver tumours
IBD
CONSIDERATIONS

Drugs
Antiretrovirals
 Anticonvulsants
 Antibiotics


‘Blood’ Conditions





Anaemia
Raynauds
SLE
Thrombogenic
Mutations
Hyperlipidaemia
CONSIDERATIONS

Cardiovascular









Smoking
Obesity
‘Multiple risk factors for Cardiovascular Disease’
Hypertension,
Ischaemic Heart Disease
Stroke
Hyperlipidaemia
Valvular / Congenital Heart Disease
Migraine
ABBREVIATIONS
CHC – Combined Hormonal Contraception
 POP – Progestogen Only Pill
 DMPA – Depot Medroxyprogesterone Acetate
 NET-EN – Norethisterone Enantanate
 IMP – Implant (Progesterone Only)
 Cu-IUD – Copper Coil
 LNG-IUD – Levonorgestrel Releasing IUD

DRUGS
THE END
Boring, wasn’t it?
 Refs:

http://www.fsrh.org/pdfs/UKMEC2009.pdf
 http://www.fsrh.org/pdfs/ukmecsummarysheets2009.
pdf
 http://www.hillingdongp.org.uk/_borders/ukmec_page
s_28-29.pdf
